3-(2-bromoethyl)benzo[d]thiazol-2(3H)-one | 98590-35-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 3-(2-bromoethyl)benzo[d]thiazol-2(3H)-one
• 英文别名: 3-(2-Bromoethyl)-1,3-benzothiazol-2-one
• CAS: 98590-35-3
• 化学式: C₉H₈BrNOS
• 分子量: 258.139
• InChiKey: GVLCDDNGSYQUIF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  45.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(2-bromoethyl)benzo[d]thiazol-2(3H)-one 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 生成 3-(6-(4-(2-(2-oxobenzo[d]thiazol-3(2H)-yl)ethyl)piperazin-1-yl)hexyl)benzo[d]thiazol-2(3H)-one
  参考文献：
  名称：

  Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents

  摘要：

  Benzoxazolone and benzothiazolone were used as template blocks to develop two series of dimers as anti-inflammatory and analgesic agents based on the concept of bivalent ligands. The first series (I) involved varying the carbon chain lengths extending from the piperazine core to the nitrogen atom of the dibenzo[d]oxazol-2(3H)-one or dibenzo[d]thiazol-2(3H)-one. The second series (II) was designed by changing the attachment point. All compounds were screened for their in vitro anti-inflammatory activity in terms of the inhibition of inducible nitric oxide synthase (iNOS) and nuclear factor kappa B (NF-kappa B). Seventeen compounds inhibited both targets. Eleven of them exhibited IC50 values below 3 mu M while five compounds showed IC50 values of 1 mu M or below. Most of the compounds were found to be devoid of cytotoxicity against mammalian kidney and solid tumors cell lines up to 25 mu g/mL. In vivo anti-inflammatory and antinociceptive studies revealed that compounds 3j, 5t and 8b have significant anti-inflammatory and analgesic activity comparable to that of indomethacin and ketorolac, respectively. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.04.057
• 作为产物：
  描述：

  2-羟基苯并噻唑 、 1,2-二溴乙烷 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以83%的产率得到3-(2-bromoethyl)benzo[d]thiazol-2(3H)-one
  参考文献：
  名称：

  苯并[d]噻唑-2(3H)酮基σ受体配体的构效关系研究

  摘要：

  在此，我们报告SAR研究，其中涉及基于苯并[ d ]噻唑-2( 3H )酮的σ受体(σ)配体的接头长度、芳基取代和烷基胺环大小的结构修饰。该系列中的许多化合物对 σ 受体亚型表现出低纳摩尔亲和力。特别是， 8a对 σ-1 受体表现出高亲和力（σ-1 K i = 4.5 nM），并对 σ-2 受体表现出中等高的选择性（483 倍）。

  DOI：

  10.1016/j.bmcl.2013.06.032

文献信息

• Conversion of a Highly Selective Sigma-1 Receptor–Ligand to Sigma-2 Receptor Preferring Ligands with Anticocaine Activity
  作者：Christophe Mésangeau、Sanju Narayanan、Andrea M. Green、Jamaluddin Shaikh、Nidhi Kaushal、Eddy Viard、Yan-Tong Xu、James A. Fishback、Jacques H. Poupaert、Rae R. Matsumoto、Christopher R. McCurdy

  DOI：10.1021/jm701357m

  日期：2008.3.13

  Cocaine's toxicity can be mitigated by blocking its interaction with sigma-1 receptors. The involvement of sigma-2 receptors remains unclear. To investigate their potential role, we have designed compounds through a convergent synthesis utilizing a highly selective sigma-1 ligand and elements of a selective sigma-2 ligand. Among the synthesized compounds was produced a subnanomolar sigma-2 ligand with an 11-fold preference over sigma-1 receptors. These compounds may be useful in developing effective pharmacotherapies for cocaine toxicity.
• Fujii, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1957, vol. 77, p. 359
  作者：Fujii

  DOI：——

  日期：——
• Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands
  作者：Sebastiano Intagliata、Hebaalla Agha、Theresa A. Kopajtic、Jonathan L. Katz、Shyam H. Kamble、Abhisheak Sharma、Bonnie A. Avery、Christopher R. McCurdy

  DOI：10.1007/s00044-020-02597-2

  日期：2020.9

  In this work we report the structure-affinity relationships, binding properties, and metabolic stability studies of a series of benzo[d]thiazol-2(3H)one as sigma receptor (sigma R) ligands. Specifically, to improve the metabolic stability of the cyclic amine fragment of our lead compound (SN56), the metabolically unstable azepane ring was replaced with a 1-adatamantamine moiety. Within the synthesized analogs, compound12had low nanomolar affinity for the sigma R-1 (K-i = 7.2 nM) and moderate preference (61-fold) over the sigma R-2. In vitro metabolic stability studies showed a slight improvement of the metabolic stability for7-12, even though an extensive metabolism in rat liver microsomes is being observed. Furthermore, metabolic soft spot identification of12suggested that theN-methyl group of the adamantyl moiety is a major site of metabolism.
• Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligands
  作者：Rohit Bhat、James A. Fishback、Rae R. Matsumoto、Jacques H. Poupaert、Christopher R. McCurdy

  DOI：10.1016/j.bmcl.2013.06.032

  日期：2013.9

  Herein we report the SAR study which involved structural modifications to the linker length, aryl substitution and alkylamine ring size of the benzo[d]thiazol-2(3H)one based sigma receptor (σ) ligands. Many compounds in this series displayed low nanomolar affinity for the σ receptor subtypes. In particular, 8a showed high affinity (σ-1 Ki = 4.5 nM) for σ-1 receptors and moderately high selectivity

  在此，我们报告SAR研究，其中涉及基于苯并[ d ]噻唑-2( 3H )酮的σ受体(σ)配体的接头长度、芳基取代和烷基胺环大小的结构修饰。该系列中的许多化合物对 σ 受体亚型表现出低纳摩尔亲和力。特别是， 8a对 σ-1 受体表现出高亲和力（σ-1 K i = 4.5 nM），并对 σ-2 受体表现出中等高的选择性（483 倍）。
• Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents
  作者：Ahmed H. Abdelazeem、Shabana I. Khan、Stephen W. White、Kenneth J. Sufka、Christopher R. McCurdy

  DOI：10.1016/j.bmc.2015.04.057

  日期：2015.7

  Benzoxazolone and benzothiazolone were used as template blocks to develop two series of dimers as anti-inflammatory and analgesic agents based on the concept of bivalent ligands. The first series (I) involved varying the carbon chain lengths extending from the piperazine core to the nitrogen atom of the dibenzo[d]oxazol-2(3H)-one or dibenzo[d]thiazol-2(3H)-one. The second series (II) was designed by changing the attachment point. All compounds were screened for their in vitro anti-inflammatory activity in terms of the inhibition of inducible nitric oxide synthase (iNOS) and nuclear factor kappa B (NF-kappa B). Seventeen compounds inhibited both targets. Eleven of them exhibited IC50 values below 3 mu M while five compounds showed IC50 values of 1 mu M or below. Most of the compounds were found to be devoid of cytotoxicity against mammalian kidney and solid tumors cell lines up to 25 mu g/mL. In vivo anti-inflammatory and antinociceptive studies revealed that compounds 3j, 5t and 8b have significant anti-inflammatory and analgesic activity comparable to that of indomethacin and ketorolac, respectively. (C) 2015 Elsevier Ltd. All rights reserved.